Sub Weeks
Main Sessions
KRX Seoul Office Conference Hall
10:00~11:30
[Session 1] Policy Session
10:00~10:30
KOSDAQ Policy Session (1): Strengthening Market Fundamentals
Wan-su LeeHead of Team, Listing, KOSDAQ Market, KRX
Wan-su Lee
Head of Team, Listing, KOSDAQ Market, KRX
Profile
Wansoo Lee is currently with the Listing Division of the KOSDAQ Market at the Korea Exchange.
Jae-hwa OhHead of Team, Listed Company Management, KOSDAQ Market, KRX
Jae-hwa Oh
Head of Team, Listed Company Management, KOSDAQ Market, KRX
Profile
Jae Hwa Oh is currently with the Listed Company Management Division of the KOSDAQ Market at the Korea Exchange.
Sung-cheon KimHead of Team, Disclosure, KOSDAQ Market, KRX
Sung-cheon Kim
Head of Team, Disclosure, KOSDAQ Market, KRX
Profile
Sung Chun Kim is currently with the Disclosure Division of the KOSDAQ Market at the Korea Exchange.
10:35~11:05
KOSDAQ Policy Session (2): Measures to Foster Innovative Companies
Seok-woo LeeHead of Team, Technology Company Listing Review, KOSDAQ Market, KRX
Seok-woo Lee
Head of Team, Technology Company Listing Review, KOSDAQ Market, KRX
Profile
Seokwoo Lee is currently with the Technology Company Listing Review Division of the KOSDAQ Market at the Korea Exchange.
Hyun-chel JinHead of Team, KONEX Market, KOSDAQ Market, KRX
Hyun-chel Jin
Head of Team, KONEX Market, KOSDAQ Market, KRX
Profile
Hyuncheol Jin is currently with the KONEX Market Division of the KOSDAQ Market at the Korea Exchange.
11:10~11:30
KOSDAQ Policy Session (3): Measures to Enhance Investor Confidence
Sung-cheon KimHead of Team, Disclosure, KOSDAQ Market, KRX
Sung-cheon Kim
Head of Team, Disclosure, KOSDAQ Market, KRX
Profile
Sung Chun Kim is currently with the Disclosure Division of the KOSDAQ Market at the Korea Exchange.
11:30~13:30
Lunch Break
13:30~16:20
[Session 2] Industry Outlook Session
13:30~14:20
Key Industry Outlook (1): Pharmaceuticals & Biotechnology
Min-yong EomAnalyst, Shinhan Securities
Min-yong Eom
Analyst, Shinhan Securities
Profile
Minyong Eom is a team head and healthcare equity analyst in the Industry Research Department at Shinhan Securities, where he covers the healthcare industry and related companies. After earning a master’s degree in Polymer Biomaterials Engineering from Ajou University, he spent six years as a research engineer on the New Drug Development Team at Ahn-Gook Pharmaceutical. Building on his industry and drug development experience, he began his career as an equity research analyst in 2021. Since 2024, he has been recognized as a Best Analyst for three consecutive years by both the Korea Economic Daily and the Maeil Business Newspaper.
14:30~15:20
Key Industry Outlook (2): Semiconductors
In-jun SonAnalyst, Eugene Investment & Securities
In-jun Son
Analyst, Eugene Investment & Securities
Profile
Injun Son is currently a semiconductor analyst at Eugene Investment & Securities. He began his career as a DRAM Process Integration (PI) engineer at SK hynix and later worked as a research associate at Kiwoom Securities and a semiconductor analyst at Heungkuk Securities. He holds a degree in Materials Science and Engineering from Yonsei University.
15:30~16:20
Key Industry Outlook (3): K-Beauty & Medical Devices
Jong-hyun ParkAnalyst, DAOL Investment & Securities
Jong-hyun Park
Analyst, DAOL Investment & Securities
Profile
Jonghyun Park is a Research Analyst at DAOL Investment & Securities, covering the cosmetics and medical devices sectors. He graduated from Yonsei University School of Business and previously worked at CGS-CIMB and QuantaMatrix before joining DAOL Investment & Securities. He was ranked No. 1 in the small-cap category of Maeil Business Economy’s 2025 Best Analyst Awards. His research focuses on the cosmetics and medical devices industries.